Key facts
- Notable investors include Frees Fund, Shenzhen GTJA Investment Group, Beijing Medical Robotics Industry Innovation Center, Global Healthcare Innovation Center.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Tsingpai Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Tsingpai Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tsingpai Technology
Developer of photoacoustic imaging systems and equipment used for medical diagnostic purposes. The company's core product, MarsonicsPIIP photoacoustic comprehensive imaging system, can image the structure and function of biological tissues, and can be used for photoacoustic imaging of small animals, large animals, and isolated tissues, and can also be used for disease detection in human body under the skin (3-4cm) and diagnosis, solving the bottleneck for imaging hemoglobin, blood oxygen, lipids, and collagen.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2022
- Website
- tsingpai.com/
- Ownership
- Privately Held (backing)
Tsingpai Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tsingpai Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tsingpai Technology in its N-PORT filings yet. We sweep new filings monthly.